In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model
Regardless of the <i>C. auris</i> clade, rezafungin activity in vivo was comparable to or improved over that of the three previously approved echinocandins.
Authors
- Jeffrey B. Locke (ORCID: https://orcid.org/0000-0001-8145-0828)
- Lajos Forgács
- Noémi Balla
- Andrew M. Borman (ORCID: https://orcid.org/0000-0003-0585-5721)
- Dávid Balázsi
- Fruzsina Kovács
- Renátó Kovács (ORCID: https://orcid.org/0000-0003-3946-2424)
- Zoltán Tóth (ORCID: https://orcid.org/0000-0002-3394-3238)
- Tugba Ilay Baran
- Chiaki Amano
- László Majoros
Institutions
- University of Debrecen (HU)
- University of Exeter (GB)
- Southmead Hospital (GB)
- Cidara Therapeutics (United States) (US)
- Medical Research Council (GB)
Publication Details
- Journal
- Journal of Fungi
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3390/jof10090617
- Citations
- 8
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- Magyar Tudományos Akadémia
- Medical Research Council
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap